Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMPRSS11D | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | CCNT2 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | KDM7A | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | ABO | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | SYN1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | GSC | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | RALGDS | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | SYTL3 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | CRYL1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | FAM50B | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |